Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is characterized by a lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) amplification [1]. This evidence concerns the gene ESR1 and breast carcinoma.